No Improvement in Lymphedema With Hypofractionated Nodal RT for Breast Cancer Numerical advantage in randomized trial, non-randomized study misses noninferiority mark Oct 01, 2024
Neurocognitive Side Effects of Brain Radiation Subside for Many, Analysis Shows In three trials, about 40% of patients with brain metastases recovered neurocognitive function Oct 01, 2024
Quality of Life Similar With Proton Beam Therapy vs IMRT for Prostate Cancer "It really shows us that we have two great options," expert says Sep 30, 2024
Lymphedema Risk No Higher With 3-Week RT Regimen in Early Breast Cancer "Nodal radiotherapy for breast cancer no longer needs 5 weeks," researcher says Sep 17, 2024
Favorable Outcomes With Microwave Ablation for Colorectal Liver Metastases Survival similar to resection with less morbidity, but editorial suggests use in select patients Aug 22, 2024
Benefits of Adjuvant RT for Early Breast Cancer Limited to First 10 Years A study's 30-year follow-up data provided no new insights into which patients benefit from RT Aug 15, 2024
Big Gain in PFS With Metastasis-Directed RT for Oligometastatic Pancreatic Cancer Fourfold improvement in median PFS when added to standard-of-care systemic therapy Aug 07, 2024
Broader Use of Cryoablation for Early Breast Cancer? High success rate, few adverse events in patients ineligible for initial trials Jul 15, 2024
Refractory Multiple Myeloma Responsive to Immunotherapy Plus Low-Dose Radiotherapy A third of patients who had received multiple prior lines of therapy responded, small study shows Jul 10, 2024
ASTRO Guideline Addresses Specifics of HPV-Associated Oropharyngeal Cancer Clinical landscape has shifted away from traditional risks for H&N cancer to HPV predominance Jun 21, 2024
Stereotactic Radiotherapy Reduces Use of Anti-VEGF Therapy in Neovascular AMD No loss in visual acuity, with reduced cost of treatment Jun 14, 2024
Near-Perfect Control of Slow-Growing Lymphoma With Low-Dose Radiotherapy All but four of 24 patients had complete responses to 4 Gy, local control rate of 96% at 3 years Jun 06, 2024
'Practice Changing' Trial for Inoperable Locally Advanced NSCLC EGFR testing now needed for all patients with stage III disease, experts say Jun 02, 2024
PSA Nadir 6 Months After Primary RT Correlates With Prostate Cancer Outcomes Or does it? Editorial questions prognostic, predictive value in contemporary practice May 22, 2024
Brachytherapy for Prostate Cancer Linked to Higher Risk of Second Pelvic Malignancy Risk for any second malignancy, death from any second malignancy not higher versus prostatectomy Apr 23, 2024
From Neurointerventional Radiologist to 'Grey's Anatomy' Sonographer A Q&A with a physician who got a taste of Hollywood Apr 23, 2024
Salvage RT After Prostatectomy Prevails in Long-Term Comparison With Adjuvant RT No difference in freedom from distant metastasis or overall survival at 10 years Apr 19, 2024
FFR-Guided Complete Revascularization Did Not Improve Outcomes in MI Patients Compared with PCI of the culprit lesion, no difference in death, MI, unplanned revascularization Apr 10, 2024
For PCI, Intravascular Ultrasound Guidance Bests Angiography Guidance Randomized trial shows better outcomes for patients with acute coronary syndromes Apr 09, 2024
Impella Pump Improves Survival in STEMI-Related Cardiogenic Shock First trial in a quarter-century to show mortality benefit in this desperately ill group Apr 09, 2024
With Ticagrelor, Aspirin May Not Be Needed After PCI for Acute Coronary Syndrome Researcher suggests findings are robust enough to change practice guidelines Apr 08, 2024
Microwave Ablation a Safer Option for Multifocal Papillary Thyroid Carcinoma? Observational study suggests promising benefits of skipping surgery Apr 02, 2024
'Excellent' Outcomes After Complete Response in Lymph Node-Positive Breast Cancer Similar survival regardless of adjuvant therapy, even with omission of RT and axillary dissection Mar 27, 2024
Big Drop in Rate of Ipsilateral Breast Cancer After DCIS Dutch study showed greater than 50% decrease from 1989-2021 with or without adjuvant RT Mar 26, 2024
Low-Dose RT Boost Wins Support for Young Patients With Early Breast Cancer A 1.6% reduction in locoregional recurrence with higher dose offset by worse cosmetic outcomes Mar 21, 2024
No OS Difference in Pancreatic Cancer With SABR vs Irreversible Electroporation PFS, adverse events also comparable with the ablative modalities after FOLFIRINOX chemotherapy Mar 21, 2024
Novel Therapy Promising for Radiation-Induced Oral Mucositis No patient with head and neck cancer developed a severe case during 7 weeks of treatment Mar 04, 2024
Gene-Guided Immunotherapy Misses Mark in Recurrent/Metastatic Head and Neck Cancer Few responses with or without guidance in small first step for "personalized" treatment Mar 04, 2024
Vismodegib-RT Regimen Achieves High Rate of Disease Control in Head and Neck BCC Local control in 91% of cases at 1 year in small prospective trial Mar 01, 2024
AI Has an Environmental Impact, Too But it may be able to deliver net carbon benefits, at least in radiology Feb 27, 2024
Intravascular Imaging-Guided PCI Reaches a Turning Point With Survival, MI Benefits Updated meta-analysis provides strong impetus for IVUS, OCT adoption Feb 21, 2024
Hyperbaric Oxygen Therapy Shows Some Benefit After Breast Cancer Irradiation However, most women declined the therapy in this study Feb 08, 2024
Study Supports High-Dose RT, Long-Term ADT as Standard for High-Risk Prostate Cancer OS, PFS, cancer-specific survival all improved, with no increase in toxicity Jan 26, 2024
New Standard for Unresectable Hepatocellular Carcinoma? Adding durvalumab and bevacizumab to transarterial chemoembolization almost doubles PFS Jan 21, 2024
Hypofractionated Chemoradiation With Adaptive SABR Appeared Effective in NSCLC Dose of 70 Gy in 15 fractions showed favorable balance between safety and efficacy in small trial Jan 12, 2024
Cancer Patients Face Frightening Delays in Treatment Approvals "For them to take weeks -- up to months -- to provide an authorization is ridiculous" Dec 30, 2023
Is Omitting Radiation Therapy in Low-Risk Breast Cancer a Good IDEA? Local recurrence rate of 1% at 5 years in women ages 50-69 with genomically low-risk disease Dec 08, 2023
De-Escalating Breast Cancer Treatment Feasible After Response to Neoadjuvant Chemo Study showed no increase in disease progression when omitting regional nodal irradiation Dec 07, 2023
TULSA Effective in Controlling Prostate Cancer Long-Term At 5 years, median PSA was reduced by 90% Dec 05, 2023
HPV Tumor DNA May Offer Early Warning of Cervical Cancer at High Risk of Relapse Worse PFS associated with circulating tumor DNA detected as early as end of treatment Nov 21, 2023
